Share on StockTwits

Skyline Medical (NASDAQ:SKLN) CFO Robert L. Myers purchased 5,000 shares of the stock on the open market in a transaction that occurred on Friday, August 22nd. The stock was purchased at an average price of $0.15 per share, with a total value of $750.00. Following the acquisition, the chief financial officer now directly owns 5,000 shares of the company’s stock, valued at approximately $750. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Skyline Medical (NASDAQ:SKLN) remained flat at $0.1395 during during mid-day trading trading on Tuesday. Skyline Medical has a 52 week low of $0.106 and a 52 week high of $0.47. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.16. The company’s market cap is $31.1 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.